These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27899186)

  • 21. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial pancreatic cancer syndromes.
    Habbe N; Langer P; Sina-Frey M; Bartsch DK
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fanconi anemia gene mutations in young-onset pancreatic cancer.
    van der Heijden MS; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 2003 May; 63(10):2585-8. PubMed ID: 12750283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
    Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
    Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas.
    Harinck F; Kluijt I; van der Stoep N; Oldenburg RA; Wagner A; Aalfs CM; Sijmons RH; Poley JW; Kuipers EJ; Fockens P; van Os TA; Bruno MJ
    J Med Genet; 2012 Jun; 49(6):362-5. PubMed ID: 22636603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.
    Murali K; Dwarte TM; Nikfarjam M; Tucker KM; Vaughan RB; Efthymiou M; Collins A; Spigelman AD; Salmon L; Johns AL; Williams DB; Delatycki MB; John T; Stoita A
    Hered Cancer Clin Pract; 2021 Aug; 19(1):33. PubMed ID: 34399810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
    Hu C; Hart SN; Bamlet WR; Moore RM; Nandakumar K; Eckloff BW; Lee YK; Petersen GM; McWilliams RR; Couch FJ
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):207-11. PubMed ID: 26483394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
    Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
    Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial pancreatic cancer.
    Hruban RH; Petersen GM; Goggins M; Tersmette AC; Offerhaus GJ; Falatko F; Yeo CJ; Kern SE
    Ann Oncol; 1999; 10 Suppl 4():69-73. PubMed ID: 10436789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic predisposition to pancreatic cancer.
    Ghiorzo P
    World J Gastroenterol; 2014 Aug; 20(31):10778-89. PubMed ID: 25152581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic carcinoma surveillance in patients with familial melanoma.
    Parker JF; Florell SR; Alexander A; DiSario JA; Shami PJ; Leachman SA
    Arch Dermatol; 2003 Aug; 139(8):1019-25. PubMed ID: 12925390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer.
    Tischkowitz MD; Sabbaghian N; Hamel N; Borgida A; Rosner C; Taherian N; Srivastava A; Holter S; Rothenmund H; Ghadirian P; Foulkes WD; Gallinger S
    Gastroenterology; 2009 Sep; 137(3):1183-6. PubMed ID: 19635604
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort.
    Schwartz M; Korenbaum C; Benfoda M; Mary M; Colas C; Coulet F; Parrin M; Jonveaux P; Ingster O; Granier S; De Mestier L; Cros J; Riffault A; Muller M; Levy P; Rebours V; Greenhalf W; Soufir N; Hammel P
    Clin Genet; 2019 Dec; 96(6):579-584. PubMed ID: 31432501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer.
    Grant RC; Al-Sukhni W; Borgida AE; Holter S; Kanji ZS; McPherson T; Whelan E; Serra S; Trinh QM; Peltekova V; Stein LD; McPherson JD; Gallinger S
    Hum Genomics; 2013 Apr; 7(1):11. PubMed ID: 23561644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial pancreatic cancer--status quo.
    Fendrich V; Langer P; Bartsch DK
    Int J Colorectal Dis; 2014 Feb; 29(2):139-45. PubMed ID: 23948969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of BRCA2 mutations in familial pancreatic cancer.
    Couch FJ; Johnson MR; Rabe KG; Brune K; de Andrade M; Goggins M; Rothenmund H; Gallinger S; Klein A; Petersen GM; Hruban RH
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):342-6. PubMed ID: 17301269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.